Abiopharma

News list

Groenewald Ferdinand 🟢 acquired 14.8K shares (1 derivative) of Alaunos Therapeutics, Inc. (TCRT) at $2.32 Filing ID: 110531

Full text

News bot Aug. 20, 2025, 11:55 p.m.
🔍 Groenewald Ferdinand (Executive)

Company: Alaunos Therapeutics, Inc. (TCRT)

Report Date: 2025-08-18
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 14,775
Detailed Transactions and Holdings:
- Acquired 10,775 shares of Common Stock (Direct)
  Date: 2025-08-18 | Code: A | equity_swap_involved: false | shares_owned_after: 10,775.00 | transaction_form_type: 4
- Acquired 4,000 shares of Employee Stock Option (right to buy) at $2.32 per share (Derivative)
  Date: 2025-08-18 | Code: A | Expires: 2035-08-17 | equity_swap_involved: false | shares_owned_after: 4,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from August 18, 2025, with the first vesting occurring on November 18, 2025 subject to the Reporting Person's continued service through each vesting date.